Perturbed membrane-binding compounds and methods of using...

Details Perturbed membrane-binding compounds and methods of using... Perturbed membrane-binding compounds and methods of using...

2011-05-24

2011-05-24

Hartley, Michael G. (Department: 1618)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

C424S009364, C424S009400

Reexamination Certificate

active

07947253

ABSTRACT:
The present invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, such as cells undergoing apoptosis or activated platelets. The invention further provides methods for utilizing said compounds in medical practice, for diagnostic and therapeutic purposes.

REFERENCES:
patent: 4187381 (1980-02-01), Holland
patent: 4578503 (1986-03-01), Ishikawa et al.
patent: 7270799 (2007-09-01), Ziv et al.
patent: 7670590 (2010-03-01), Ziv et al.
patent: 2 197 873 (1974-03-01), None
patent: 2 274 600 (1976-01-01), None
patent: 1401579 (1975-07-01), None
patent: 57 085338 (1982-05-01), None
patent: WO 97/00848 (1997-01-01), None
patent: WO 02/46147 (2002-06-01), None
Gershon H. Organic fluorine compounds.II., Journal of Medicinal Chemistry 1967, p. 186-188, vol. 10, No. 2, American Chemical Society.
Bevers, E.M., et al., Lipid translocation across the plasma membrane of mammalian cells, Biochimica et Biophysica Acta 1439 (1999) 317-330 Elsevier.
Bombeli, T., et al, Apoptotic Vascular Endothelial Cells Become Procoagulant, Blood, Apr. 1, 1997, pp. 2429-2442, vol. 89, No. 7. American Society of Hematology, Washington DC.
Bratton, D.L., et al, Appearance of Phosphatidylserine on Apoptotic Cells Requires Calcium-mediated Nonspecific Flip-Flop and is Enhanced by Loss of the Aminophospholipid Translocase, The Journal of Biological Chemistry, Oct. 17, 1997, pp. 26159-26165, vol. 272, No. 42, The American Society for Biochemistry and Molecular Biology, Inc.
Bursch, W., et al, Cell death by apoptosis and its protective role against disease, Trends Pharmacol Sci. Jun. 1992; 13(6):245-51.
Kockx M.M., et al, Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc. Res., 2000, 736-746, vo. 45, Elsevier.
Mallat, Z., et al, Colocalization of CPP-32 With Apoptotic Cells in Human Atherosclerotic Plaques Circulation, 1997; 424-428 vol. 96, American Heart Association, Inc.
Martin, S., et al, Early Redistribution of Plasma Membrane Phosphatidylserine Is a General Feature of Apoptosis Regardless of the Initiating Stimulus: Inhibition by Overexpression of Bcl-2 and Abl, J. Exp.Med, Nov. 1995, 1545 vol. 182.
Pugsley, W., et al The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning, Stroke, 1994, 1393-1399, vol. 25, American Heart Association.
Sims, P.J., et al, Unraveling the Mysteries of Phospholipid Scrambling Thromb. Haemost, 2001; p. 266-75, vol. 86, Schattauer GmbH, Stuttgart.
Stary, H.C., et al., A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis, Circulation, 1995, p. 1355-1374, vol. 92, American Heart Association, Inc.
Van Den Eijnde, S.M., et al, Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis, Cell Death Differentiation, 1997, p. 311-316, vol. 4, Stockton Press.
JoAnne Stubbe et al. Are Carboxylations Involving Biotin Concerted or Nonconcerted? The Journal of Biological Chemistry vol. 25, No. 1 Issue of Jan. 10, pp. 236-242, 1980. Graduate Dept. of Biochemistry, Brandies University, Waltham, MA, USA & Dept. of Pharmacology, Yael University, New Haven, Connecticut, USA.
Peggy L. Olive et al. Characterization of the Uptake and Toxicity of a Fluorescent Thiol Reagent Cytometry by the Society for Analytical Cytology pp. 349-353 vol. 3, No. 5, Jul. 12, 1982 The John Hopkins Oncology Center, Section of Radiobiology, Baltimore, Maryland USA & Dept. of Radiology, Case Western Reserve University, Cleveland, Ohio, USA.
International Search Report for PCT/IL05/00055 mailed Jul. 21, 2005.

Affiliated with

Also associated with

Rating

Perturbed membrane-binding compounds and methods of using... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Perturbed membrane-binding compounds and methods of using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Perturbed membrane-binding compounds and methods of using... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2663780